Industry
Biotechnology
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
Loading...
Open
N/A
Mkt cap
N/A
Volume
N/A
High
N/A
P/E Ratio
N/A
52-wk high
N/A
Low
N/A
Div yield
N/A
52-wk low
N/A
Portfolio Pulse from Benzinga Insights
April 10, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
April 10, 2024 | 4:31 pm
Portfolio Pulse from Benzinga Insights
April 04, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Insights
April 03, 2024 | 12:09 pm
Portfolio Pulse from Avi Kapoor
April 02, 2024 | 5:23 pm
Portfolio Pulse from Benzinga Insights
April 02, 2024 | 4:31 pm
Portfolio Pulse from Avi Kapoor
April 01, 2024 | 6:31 pm
Portfolio Pulse from Benzinga Newsdesk
March 04, 2024 | 1:33 pm
Portfolio Pulse from Benzinga Insights
February 19, 2024 | 9:30 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.